University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Advanced Malignancies, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.
Sponsors: TopAlliance Biosciences, Miltenyi Biomedicine GmbH, Takeda.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has 4 clinical trials on record, with 3 currently active. Their work covers Advanced Malignancies, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.
Yes — University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.